LIVZON PHARMAC Ownership

LP6 Stock  EUR 3.40  0.18  5.59%   
LIVZON PHARMAC GRP maintains a total of 309.83 Million outstanding shares. LIVZON PHARMAC GRP holds noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as LIVZON PHARMAC in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of LIVZON PHARMAC, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LIVZON PHARMAC GRP. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

LIVZON Stock Ownership Analysis

About 53.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 30th of May 2022. LIVZON PHARMAC GRP had 13:10 split on the 3rd of July 2019. Livzon Pharmaceutical Group Inc. engages in the research, development, production, and distribution of pharmaceutical products in the Peoples Republic of China. Livzon Pharmaceutical Group Inc. was founded in 1985 and is based in Zhuhai, China. Livzon Pharmaceutical operates under Drug Manufacturers - Specialty Generic classification in Germany and traded on Frankfurt Stock Exchange. It employs 6963 people. To find out more about LIVZON PHARMAC GRP contact the company at 86 75 6813 5859 or learn more at http://www.livzon.com.cn.

LIVZON PHARMAC Outstanding Bonds

LIVZON PHARMAC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LIVZON PHARMAC GRP uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LIVZON bonds can be classified according to their maturity, which is the date when LIVZON PHARMAC GRP has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in LIVZON Stock

LIVZON PHARMAC financial ratios help investors to determine whether LIVZON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LIVZON with respect to the benefits of owning LIVZON PHARMAC security.